Marek Grabiec

974 total citations
71 papers, 707 citations indexed

About

Marek Grabiec is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Marek Grabiec has authored 71 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 16 papers in Oncology and 15 papers in Obstetrics and Gynecology. Recurrent topics in Marek Grabiec's work include Ovarian cancer diagnosis and treatment (16 papers), Cancer Risks and Factors (8 papers) and Reproductive System and Pregnancy (8 papers). Marek Grabiec is often cited by papers focused on Ovarian cancer diagnosis and treatment (16 papers), Cancer Risks and Factors (8 papers) and Reproductive System and Pregnancy (8 papers). Marek Grabiec collaborates with scholars based in Poland, Germany and Spain. Marek Grabiec's co-authors include Małgorzata Walentowicz‐Sadlecka, Paweł Sadłecki, Andrzej Marszałek, Alina Sokup, Magdalena Bodnar, Łukasz Wicherek, Paweł Basta, Wojciech Jóźwicki, Marcin Majka and Anna Knafel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Marek Grabiec

66 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Grabiec Poland 15 250 235 152 145 109 71 707
Aki Isobe Japan 15 232 0.9× 177 0.8× 244 1.6× 183 1.3× 166 1.5× 25 800
Joachim Alfer Germany 14 135 0.5× 143 0.6× 315 2.1× 223 1.5× 126 1.2× 27 819
Małgorzata Walentowicz‐Sadlecka Poland 14 130 0.5× 128 0.5× 126 0.8× 52 0.4× 94 0.9× 40 488
Élodie Chantalat France 14 248 1.0× 235 1.0× 75 0.5× 103 0.7× 127 1.2× 65 749
Alessandro Lucidi Italy 16 368 1.5× 216 0.9× 162 1.1× 35 0.2× 154 1.4× 47 742
Rosekeila Simões Nomelini Brazil 14 164 0.7× 250 1.1× 95 0.6× 183 1.3× 235 2.2× 67 653
Paweł Basta Poland 15 194 0.8× 200 0.9× 72 0.5× 266 1.8× 107 1.0× 49 544
Heung Yeol Kim South Korea 14 199 0.8× 175 0.7× 93 0.6× 111 0.8× 182 1.7× 38 532
Masahito Mizuuchi Japan 13 108 0.4× 101 0.4× 151 1.0× 126 0.9× 164 1.5× 26 526
Lee‐Wen Huang Taiwan 19 171 0.7× 350 1.5× 188 1.2× 44 0.3× 157 1.4× 45 985

Countries citing papers authored by Marek Grabiec

Since Specialization
Citations

This map shows the geographic impact of Marek Grabiec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Grabiec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Grabiec more than expected).

Fields of papers citing papers by Marek Grabiec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Grabiec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Grabiec. The network helps show where Marek Grabiec may publish in the future.

Co-authorship network of co-authors of Marek Grabiec

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Grabiec. A scholar is included among the top collaborators of Marek Grabiec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Grabiec. Marek Grabiec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sadłecki, Paweł, et al.. (2018). Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers. Tumor Biology. 40(6). 3726240080–3726240080. 10 indexed citations
3.
Grabiec, Marek, et al.. (2017). Obstetric outcomes of pre-induction of labor with a 200 μg misoprostol vaginal insert. Ginekologia Polska. 88(11). 606–612. 4 indexed citations
4.
Sadłecki, Paweł, et al.. (2016). Serum 25(OH) Vitamin D Levels in Polish Women during Pregnancies Complicated by Hypertensive Disorders and Gestational Diabetes. International Journal of Molecular Sciences. 17(10). 1574–1574. 15 indexed citations
5.
Sadłecki, Paweł, Marek Grabiec, & Małgorzata Walentowicz‐Sadlecka. (2016). Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus. PLoS ONE. 11(9). e0162957–e0162957. 25 indexed citations
6.
Sadłecki, Paweł, et al.. (2014). [Indications for genetic amniocentesis investigated at the Department of Gynecology, Obstetrics, and Oncologic Gynecology, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz].. PubMed. 85(6). 420–3. 4 indexed citations
7.
Walentowicz‐Sadlecka, Małgorzata, et al.. (2014). The Preoperative Maximum Standardized Uptake Value Measured by 18F-FDG PET/CT as an Independent Prognostic Factor of Overall Survival in Endometrial Cancer Patients. BioMed Research International. 2014. 1–7. 28 indexed citations
8.
Sadłecki, Paweł, Magdalena Bodnar, Marek Grabiec, et al.. (2014). The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients. BioMed Research International. 2014. 1–11. 57 indexed citations
9.
Bajek, Anna, Joanna Olkowska, Natalia Gurtowska, et al.. (2014). Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine. Expert Opinion on Biological Therapy. 14(6). 831–839. 9 indexed citations
10.
Sadłecki, Paweł, et al.. (2013). Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer. International Journal of Endocrinology. 2013. 1–6. 5 indexed citations
11.
Knapp, Paweł, et al.. (2013). Expression of Estrogen Receptors (α, β), Cyclooxygenase-2 and Aromatase in normal endometrium and endometrioid cancer of uterus. Advances in Medical Sciences. 58(1). 96–103. 19 indexed citations
12.
Grabiec, Marek, et al.. (2013). Evaluation of the efficacy and safety of Foley catheter pre-induction of labor. Ginekologia Polska. 84(3). 180–5. 9 indexed citations
13.
Grabiec, Marek, et al.. (2013). The role of vitamin D in the carcinogenesis of breast and ovarian cancer. Ginekologia Polska. 84(4). 305–8. 24 indexed citations
14.
Odrowąż‐Sypniewska, Grażyna, et al.. (2013). Analysis of serum protein fractions from women with recurrent miscarriage. Ginekologia Polska. 84(10). 851–6. 1 indexed citations
15.
Walentowicz‐Sadlecka, Małgorzata, Paweł Sadłecki, Andrzej Marszałek, & Marek Grabiec. (2012). [Cigarette smoking among women attending cervical cancer screening program].. PubMed. 69(10). 914–7. 1 indexed citations
16.
Sadłecki, Paweł, Małgorzata Walentowicz‐Sadlecka, & Marek Grabiec. (2011). Serum epidermal growth factor levels in epithelial ovarian tumours. 10(3). 187–190. 2 indexed citations
17.
Sadłecki, Paweł, Małgorzata Walentowicz‐Sadlecka, & Marek Grabiec. (2010). Angiogenesis in neoplastic processes. 9(1). 28–31. 1 indexed citations
18.
Blecharz, Paweł, Joanna Skręt‐Magierło, Paweł Basta, et al.. (2009). Stężenie sHLA-G i sRCAS1 w osoczu kobiet leczonych operacyjnie z powodu raka sromu jako wskaźnik stanu mikrośrodowiska raka. Jagiellonian University Repository (Jagiellonian University). 7(3). 192–198.
19.
Szymański, Wiesław, et al.. (2003). [Neo-angiogenesis in immunohistochemical techniques as a prognostic factor in endometrial carcinoma].. PubMed. 74(9). 885–91. 1 indexed citations
20.
Szymański, Wiesław, et al.. (2002). [Microvessel density index as a prognostic factor in a low histological differentiation stage of endometrial carcinoma].. PubMed. 73(11). 951–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aki Isobe Breakdown of academic impact, for papers by Joachim Alfer Breakdown of academic impact, for papers by Małgorzata Walentowicz‐Sadlecka Breakdown of academic impact, for papers by Élodie Chantalat Breakdown of academic impact, for papers by Alessandro Lucidi Breakdown of academic impact, for papers by Rosekeila Simões Nomelini Breakdown of academic impact, for papers by Paweł Basta Breakdown of academic impact, for papers by Heung Yeol Kim Breakdown of academic impact, for papers by Masahito Mizuuchi Breakdown of academic impact, for papers by Lee‐Wen Huang
Rankless by CCL
2026